Clinical Trial Site

Bethlehem, Pennsylvania 18017

0 studies enrolling now · 2 studies all time

What they study most

Hereditary Transthyretin-mediated (ATTRv) Amyloidosis, High Cardiovascular Risk, Hypertension, Polyneuropathy

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation — Completed